Amendment requires an HHS study to identify conditions without an FDA-approved treatment where the development of a treatment would fill an unmet medical need for a serious or life-threatening condition or rare disease. Also, the amendment requires HHS to identify appropriate incentives that would lead to the development of such treatments.

passedUnited States· United States Congress· EN

Introduced

—

Last action

—

Status

On agreeing to the Gottheimer amendment (A007) Agreed to by recorded vote: 380 - 45 (Roll no. 678).

Records

Official amendment HAMDT 717 (116th) from United States at United States Congress. Status: On agreeing to the Gottheimer amendment (A007) Agreed to by recorded vote: 380 - 45 (Roll no. 678)..

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Vertaal naar

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Related records

amends → Elijah E. Cummings Lower Drug Costs Now Act

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/amendment/116th-congress/hamdt-717
Open data entity: https://api.congress.gov/v3/amendment/116/hamdt/717
us · 116-hamdt-717 · source updated 8 February 2022